We are the producer of Gold Standard in Mastitis Prevention
IMMVAC, Inc. manufactures vaccines and serums for production and companion animals to aid in the protection and treatment of virtually all gram-negative bacteria. IMMVAC products are based on two exclusively-owned core technologies:
1. a patented genetically-engineered gram-negative mutant Bacterin, Re 17, which is comprised of the universal core antigen common to all gram-negative bacteria; and 2. a patented immunopotentiator, E3, which stimulates production of B- and T-lymphocytes, thereby enhancing an animal’s overall immunity to disease.
IMMVAC INC. was founded in 1983, primarily to commercialize novel technology developed by Dr. Ronald F. Sprouse, Professor of Pathology, at the University of Missouri School of Medicine.
Please enter your phone number and click "Send" to receive the listing details by SMS.
For numbers outside the US, please enter the country code, for e.g. +91.
If you do not receive a message, your phone number might be registered in the Do Not Disturb Registry.
Number:
For numbers outside the US please enter the country code.
Please enter your phone number and click "Call" to call the listing owner.
Number:
For numbers outside the US please enter the country code.
